187.17
price up icon1.72%   3.17
pre-market  プレマーケット:  186.04   -1.13   -0.60%
loading

なぜBecton Dickinson Co(BDX)の株価が下がっていますか?

2025-05-01 の取引セッション中に、Becton Dickinson Co (BDX) 株の 18.13% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。
2023-11-09:

Shares of Becton Dickinson And Company (BDX) dropped by 9.25% from $255.92 to $232.24 in the trading on Thursday, Novemeber 9, 2023. The reasons why BDX down include:

  • Mixed Q4 Earnings: BD reported adjusted earnings per share (EPS) of $3.42 for Q4 2023, marking a 24.4% year-over-year increase. However, this figure was in line with analyst expectations, leading to mixed sentiment. The full-year adjusted EPS of $12.21 represented a 7.6% increase compared to the previous fiscal year but slightly missed the consensus estimate. BD's Q4 2023 revenues were $5.09 billion, surpassing expectations and showing a 6.8% year-over-year growth. Full-year revenues also exceeded estimates. BD's various business segments, including BD Medical, BD Life Sciences, and BD Interventional, reported revenue performances in line with or slightly below analysts' estimates.
  • Concerns about margin contraction: BD's gross profit decreased by 18.1% in Q4, with a significant gross margin contraction of 1017 basis points. Operating profit and margin also saw declines.
  • Disappointing FY2024 Guidance: BD provided its fiscal 2024 outlook, with projected revenues, organic revenue growth, and adjusted EPS falling within the range of analyst expectations.
medical_instruments_supplies RMD
$273.73
price up icon 0.99%
medical_instruments_supplies ALC
$74.51
price up icon 0.54%
medical_instruments_supplies WST
$262.33
price up icon 0.77%
$67.49
price up icon 0.51%
medical_instruments_supplies COO
$68.56
price up icon 1.32%
大文字化:     |  ボリューム (24 時間):